Because Bach1 protein nuclear exportation and subsequent degradation is controlled by tyrosine phosphorylation [26], we assumed that tyrosine kinase inhibitors would reverse DHA-induced Bach1 degradation and block HO-1 induction by DHA, thus leading to enhanced cytotoxicity upon cancer cells. Here, BACH1 is linked to cancer.